This article has been cited by
1Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
Md. Motiur Rahman,Yasser Alatawi,Ning Cheng,Jingjing Qian,Annya V. Plotkina,Peggy L. Peissig,Richard L. Berg,David Page,Richard A. Hansen
Epilepsy Research.2017;135()71
[DOI]
2A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
Massimo Calderazzo,Pierandrea Rende,Paolo Gambardella,Giovambattista De Sarro,Luca Gallelli
Drug Safety - Case Reports.2015;2(1)71
[DOI]
3Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report
Benedetto Caroleo,Alberto Migliore,Erika Cione,Stefania Zampogna,Francesco Perticone,Giovambattista De Sarro,Luca Gallelli
Current Drug Safety.2019;14(2)147
[DOI]
4Itraconazole
Benedetto Caroleo,Alberto Migliore,Erika Cione,Stefania Zampogna,Francesco Perticone,Giovambattista De Sarro,Luca Gallelli
Reactions Weekly.2014;1502(1)23
[DOI]
5Involvement of Campylobacter jejuni in septic arthritis: a case report
Manuela Colosimo,Anna Grancini,Laura Daprai,Aldo Giovanni Cimminiello,Cristina Castelli,Antonella Restelli,Luca Gallelli,Erminio Torresani
JMM Case Reports.2015;2(5)23
[DOI]
  Feedback 
  Subscribe